Cargando…
Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice
Brain metastases (BM) are frequently detected during the follow-up of patients with malignant tumors, particularly in those with advanced disease. Despite a major progress in systemic anti-cancer treatments, the average overall survival of these patients remains limited (6 months from diagnosis). Al...
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423367/ https://www.ncbi.nlm.nih.gov/pubmed/34504791 http://dx.doi.org/10.3389/fonc.2021.714514 |